IRadimed Corp reports results for the quarter ended in September - Earnings Summary

IRADIMED

03/11/2023 13:32

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
43 cents​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of 29 cents.  The mean expectation of three analysts for the
quarter was for earnings of 36 cents per share. Wall Street
expected results to range from 36 cents to 37 cents per share.
    * Revenue rose 23.1% to $16.51 million from a year ago;
analysts
expected $16.18 million. 
    * IRadimed Corp's reported EPS for the quarter was 40
cents​.
    * The company reported quarterly net income of $5.07
million.
    * IRadimed Corp shares had fallen by 7.6% this quarter and
gained 49.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for IRadimed Corp is
$60.00 
This summary was machine generated from LSEG data November 3 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.36           0.43           Beat
 Jun. 30 2023      0.31           0.36           Beat
 Mar. 31 2023      0.28           0.30           Beat
 Dec. 31 2022      0.30           0.32           Beat